THE PHARMACOLOGY OF CARIPRAZINE, A NOVEL D3-PREFERRING D3/D2 ANTAGONIST-PARTIAL AGONIST ANTIPSYCHOTIC

被引：0
|
作者：
Kiss, Bela [1 ]
Seneca, Nick [2 ]
Szikra, Judit [1 ]
Nemethy, Zsolt [1 ]
Saghy, Katalin [1 ]
Laszy, Judit [1 ]
Gyertyan, Istvan [1 ]
机构：
[1] Gedeon Richter, Budapest, Hungary
[2] Karolinska Inst, Stockholm, Sweden
来源：
SCHIZOPHRENIA RESEARCH | 2010年 / 117卷 / 2-3期
关键词：
D O I：
10.1016/j.schres.2010.02.680
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：379 / 380
页数：2
相关论文
共 50 条
  • [31] Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson's disease
    Piercey, MF
    [J]. CLINICAL NEUROPHARMACOLOGY, 1998, 21 (03) : 141 - 151
  • [32] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Paul W. Czoty
    H. Donald Gage
    Pradeep K. Garg
    Sudha Garg
    Michael A. Nader
    [J]. Psychopharmacology, 2014, 231 : 613 - 619
  • [33] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Czoty, Paul W.
    Gage, H. Donald
    Garg, Pradeep K.
    Garg, Sudha
    Nader, Michael A.
    [J]. PSYCHOPHARMACOLOGY, 2014, 231 (03) : 613 - 619
  • [34] Blonanserin, an Antipsychotic and Dopamine D2/D3 Receptor Antagonist, and Ameliorated Alcohol Dependence
    Takaki, Manabu
    Ujike, Hiroshi
    [J]. CLINICAL NEUROPHARMACOLOGY, 2013, 36 (02) : 68 - 69
  • [35] DOPAMINE D2 AND D3 RECEPTOR OCCUPANCY OF CARIPRAZINE IN SCHIZOPHRENIC PATIENTS
    Keator, David B.
    Mukherjee, J.
    Preda, A.
    Highum, D.
    Lakatos, A.
    Gage, A.
    Potkin, S. G.
    [J]. SCHIZOPHRENIA BULLETIN, 2009, 35 : 154 - 154
  • [36] On dopamine D2 and D3 receptor pharmacology - Ekman,A
    不详
    [J]. NORDIC JOURNAL OF PSYCHIATRY, 1996, 50 (06) : 499 - 500
  • [37] Dopamine D3 and D2 receptor occupancy of cariprazine in schizophrenic patients
    Potkin, S.
    Keator, D.
    Mukherjee, J.
    Preda, A.
    Highum, D.
    Gage, A.
    Xie, J.
    Ghahramani, P.
    Laszlovsky, I.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S316 - S316
  • [38] The identification of a selective dopamine D2 partial agonist, D3 antagonist displaying high levels of brain exposure
    Holmes, Ian P.
    Blunt, Richard J.
    Lorthioir, Olivier E.
    Blowers, Stephen M.
    Gribble, Andy
    Payne, Andrew H.
    Stansfield, Ian G.
    Wood, Martyn
    Woollard, Patrick M.
    Reavill, Charlie
    Howes, Claire M.
    Micheli, Fabrizio
    Di Fabio, Romano
    Donati, Daniele
    Terreni, Silvia
    Hamprecht, Dieter
    Arista, Luca
    Worby, Angela
    Watson, Steve P.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (06) : 2013 - 2016
  • [39] Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 oil dialysate dopamine levels
    Zapata, A
    Shippenberg, TS
    [J]. NEUROPHARMACOLOGY, 2005, 48 (01) : 43 - 50
  • [40] Acute D2/D3 dopaminergic agonism but chronic D2/D3 antagonism prevents NMDA antagonist neurotoxicity
    Farber, Nuri B.
    Nemmers, Brian
    Noguchi, Kevin K.
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 60 (06) : 630 - 638
12345